Global Holmium-166 Microsphere Market Growth 2024-2030
Holmium-166 (Ho-166) microspheres are tiny radioactive particles used in a medical procedure called selective internal radiation therapy (SIRT) or radioembolization. This treatment is primarily used for patients with liver cancer, specifically hepatocellular carcinoma or metastatic liver tumors from colorectal cancer.
The global Holmium-166 Microsphere market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Holmium-166 Microsphere Industry Forecast” looks at past sales and reviews total world Holmium-166 Microsphere sales in 2023, providing a comprehensive analysis by region and market sector of projected Holmium-166 Microsphere sales for 2024 through 2030. With Holmium-166 Microsphere sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Holmium-166 Microsphere industry.
This Insight Report provides a comprehensive analysis of the global Holmium-166 Microsphere landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Holmium-166 Microsphere portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Holmium-166 Microsphere market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Holmium-166 Microsphere and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Holmium-166 Microsphere.
United States market for Holmium-166 Microsphere is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Holmium-166 Microsphere is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Holmium-166 Microsphere is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Holmium-166 Microsphere players cover Terumo Europe, NuclMed Care, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Holmium-166 Microsphere market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Biodegradable
Others
Segmentation by Application:
Direct Intratumoral Therapy
Radioactive Embolization (Sirt) Treatment
Radionuclide Targeted Therapy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Terumo Europe
NuclMed Care
Key Questions Addressed in this Report
What is the 10-year outlook for the global Holmium-166 Microsphere market?
What factors are driving Holmium-166 Microsphere market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Holmium-166 Microsphere market opportunities vary by end market size?
How does Holmium-166 Microsphere break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.